These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 1948753

  • 1. [The factors that determine the manifestation of uremic poisoning during the development of chronic kidney failure].
    Rumiantsev ASh, Panina IIu, Kozlov VV, Lukichev BG, Tsiura VI, Kaznacheeva IG, Abdiadilova LV.
    Ter Arkh; 1991; 63(6):71-4. PubMed ID: 1948753
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. [A comparative evaluation of the efficacy of the clinical use of SKN-4M-, SKT-6A- and polifepan-type sorbents in treating patients with chronic kidney failure (clinical and experimental studies)].
    Ryss ES, Riabov SI, Lutoshkin MB.
    Ter Arkh; 1996 Nov; 68(8):39-43. PubMed ID: 9019830
    [Abstract] [Full Text] [Related]

  • 4. An update on uremic toxins.
    Ringoir S.
    Kidney Int Suppl; 1997 Nov; 62():S2-4. PubMed ID: 9350668
    [Abstract] [Full Text] [Related]

  • 5. Renal handling of middle molecules in uremic patients and in the isolated rat kidney.
    Lustenberger N, Schindhelm K, Nordmeyer C, Schurek HJ, Stolte H.
    Artif Organs; 1981 Nov; 4 Suppl():110-4. PubMed ID: 7295076
    [Abstract] [Full Text] [Related]

  • 6. [The secretory performance of eccrine sweat glands from the nephrologic viewpoint--II: Middle molecules].
    Koban F, Adler D, Gens C, Gehrisch S, Rose W, Hornak H, Heinrich HG.
    Z Gesamte Inn Med; 1989 May 01; 44(9):257-60. PubMed ID: 2741521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Vitamin K1 and C metabolism in uremia during hemodialysis].
    Bakaev VV, Khomenko VF.
    Urol Nefrol (Mosk); 1991 May 01; (1):40-3. PubMed ID: 1858205
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V, Cappelli P, Amoroso L, Di Liberato L, Muscianese P, Santarelli P, Del Rosso G, Bonomini M.
    G Ital Nefrol; 2004 May 01; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The anglerfish and uremic toxins.
    Lowenstein J.
    FASEB J; 2011 Jun 01; 25(6):1781-5. PubMed ID: 21622695
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.